1. The use of pentoxifylline might enhance the effect of chemotherapy or radiotherapy in reducing tumor growth

   • Kadri Altundag

   Letter to the Editor 19 May 2023 Article: 183

2. Echinocystic acid induces the apoptosis, and inhibits the migration and invasion of non-small cell lung cancer cells

   • Duojie Zhu
   • Bin Li
   • Yumin Li

   Original Paper 19 May 2023 Article: 182

   

3. Biology of breast cancer brain metastases and novel therapies targeting the blood brain barrier: an updated review

   • Hongfang Zhao
   • Luxuan Wang
   • Chunhui Li

   Review Article 18 May 2023 Article: 181

   

4. Elacestrant: a new FDA-approved SERD for the treatment of breast cancer

   • Neha Bhatia
   • Suresh Thareja

   Review Article 16 May 2023 Article: 180

   

5. Apelin receptor antagonist boosts dendritic cell vaccine efficacy in controlling angiogenic, metastatic and apoptotic-related factors in 4T1 breast tumor-bearing mice

   • Javad Masoumi
   • Nahid Zainodini
   • Abdollah Jafarzadeh

   Original Paper 15 May 2023 Article: 179

   

6. Istradefylline induces A2A/P2X7 crosstalk expression inducing pro-inflammatory signal, and reduces AKT/mTOR signaling in melanoma-bearing mice

   • Jean L. Gutknecht da Silva
   • Daniela F. Passos
   • Daniela B. R. Leal

   Original Paper 15 May 2023 Article: 178

   

7. Long non-coding RNAs in breast cancer stem cells

   • Yuting Huang
   • Wenju Mo
   • Yuqin Ding

   Review Article 13 May 2023 Article: 177

   

8. Tumor infiltrating lymphocytes and radiological picture of the tumor

   • Karolina Frankowska
   • Michał Zarobkiewicz
   • Agnieszka Bojarska-Junak

   Review Article Open access 13 May 2023 Article: 176

   

9. Arginine deiminase produced by lactic acid bacteria as a potent anti-cancer drug

   • Darshali P. Thakker
   • Rajnish Narayanan

   Review Article 12 May 2023 Article: 175

   

10. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes

    • Rhuthuparna Malayil
    • Yogita Chhichholiya
    • Anjana Munshi

    Review Article 11 May 2023 Article: 174

    

11. Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies

    • Fauziya
    • Akash Gupta
    • Farhan J. Ahmad

    Review Article 10 May 2023 Article: 173

    

12. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia

    • Chie Ishikawa
    • Naoki Mori

    Original Paper 10 May 2023 Article: 172

    

13. Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review

    • Suvitha Anbarasu
    • Anand Anbarasu

    Review Article 10 May 2023 Article: 171

    

14. Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells

    • Akram Firouzi Amandi
    • Elham Jokar
    • Babak Nejati

    Original Paper 08 May 2023 Article: 170

    

15. Anti-proliferative, apoptosis inducing, and antioxidant potential of Callistemon lanceolatus bark extracts: an in vitro and in silico study

    • Ramesh Kumar
    • Prem Prakash Kushwaha
    • Abhay Kumar Pandey

    Original Paper 08 May 2023 Article: 169

    

16. Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes

    • Mohammad Hossein Kazemi
    • Mahdieh Shokrollahi Barough
    • Reza Falak

    Original Paper Open access 06 May 2023 Article: 168

    

17. The roles of EZH2 in cancer and its inhibitors

    • Yuankai Liu
    • Qiong Yang

    Review Article 06 May 2023 Article: 167

    

18. Fundamental concepts of protein therapeutics and spacing in oncology: an updated comprehensive review

    • Bahareh Farasati Far
    • Maryam Safaei
    • Mohammad Reza Naimi-Jamal

    Review Article 05 May 2023 Article: 166

    

19. Vitamin-based radiopharmaceuticals for tumor imaging

    • Meryem Cansu Sahin
    • Senem Sanli

    Review Article 02 May 2023 Article: 165

20. Do cancers have their origins in embryonic development or in primitive organisms?

    • Jinsong Liu

    Letter to the Editor 01 May 2023 Article: 164

21. BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

    • Marcel Ebeling
    • Mario Scheurer
    • Frank Wilde

    Review Article Open access 28 April 2023 Article: 163

    

22. Analgesics can affect the sensitivity of temozolomide to glioma chemotherapy through gap junction

    • Suzhi Zhang
    • Sanxing Guo
    • Xiaojian Zhang

    Original Paper 26 April 2023 Article: 162

    

23. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis

    • Haofuzi Zhang
    • Mingdong Bao
    • Xiaofan Jiang

    Original Paper 26 April 2023 Article: 161

    

24. Unlocking the mystery associated with infertility and prostate cancer: an update

    • Anirban Goutam Mukherjee
    • Abilash Valsala Gopalakrishnan

    Review Article 26 April 2023 Article: 160

    

25. A review on emerging targeted therapies for the management of metastatic colorectal cancers

    • Rohitas Deshmukh
    • Mahendra Prajapati
    • Ranjit K. Harwansh

    Review Article 25 April 2023 Article: 159

    

26. Important oncogenic and immunogenic roles of SPP1 and CSF1 in hepatocellular carcinoma

    • Tianxin Xiang
    • Na Cheng
    • Ping Zeng

    Original Paper Open access 25 April 2023 Article: 158

    

27. Classification of triple-negative breast cancer based on pathway enrichment levels

    • Qian Liu
    • Xiaosheng Wang

    Original Paper 24 April 2023 Article: 157

    

28. LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells

    • Hassan Dianat-Moghadam
    • Soheil Abbasspour-Ravasjani
    • Mahammad Nouri

    Original Paper 24 April 2023 Article: 156